Integra LifeSciences Holdings Corporation ( IART) - Key Metrics
IART Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $5.67 | -$0.02 | $0.15 | -$0.49 |
| 2025Q3 | $5.24 | -$0.07 | $0.53 | $0.34 |
| 2025Q2 | $5.44 | -$6.33 | $0.12 | -$0.15 |
| 2025Q1 | $5 | -$0.33 | -$0.15 | -$0.53 |
IART Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -139.86 |
| 2025Q3 | ? | -50.88 |
| 2025Q2 | ? | -0.48 |
| 2025Q1 | ? | -16.62 |
IART Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -0.70% | ? |
| 2025Q4 | -2.06% | ? |
| 2025Q3 | 2.34% | ? |
| 2025Q2 | -1.20% | ? |
| 2025Q1 | -2.39% | ? |
IART
Price: $19.79
52 week price:
Payout Ratio Range:
Earnings Per Share: -6.47 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 405021
Ebitda: 31.0 millionMarket Capitalization: 1.4 billion